---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-135204"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:44:12.319997+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics upsizes ATM offering by up to $25M, previously raised $16M

## Summary
- Filed prospectus supplement on Dec 10, 2024 for additional gross proceeds up to $25M.
- Prior sales under same ATM agreement totaled approx $16M gross proceeds.
- Sales agent is H.C. Wainwright & Co., LLC under agreement dated Oct 7, 2022.
- Shares offered via S-3 registration statement; legal opinion from A&L Goodbody LLP attached.

## SEC filing metadata
- accession: 0000950170-24-135204
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/0000950170-24-135204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/itrm-20241210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-135204
- JSON: https://secwatch.observer/filing/0000950170-24-135204.json
- Plain text: https://secwatch.observer/filing/0000950170-24-135204.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.